REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Port Pharma I, S. R. O. (Slovakia)

Main Activities: Other Business Support Services | All Other Business Support Services
Full name: Port Pharma I, S. R. O. Profile Updated: July 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Port Pharma I, S. R. O. is a company in Slovakia, with a head office in Bratislava. It operates in the Other Business Support Services industry. Port Pharma I, S. R. O. was incorporated on January 01, 2022. It currently has a total number of 3 - 4 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 51.07% in 2024. Its’ total assets recorded a growth of 42.51%. Port Pharma I, S. R. O.’s net profit margin increased by 0.27% in 2024.

Headquarters
Bancikovej, 1/A
Bratislava; Bratislavsky; Postal Code: 82103

Contact Details: Purchase the Port Pharma I, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Port Pharma I, S. R. O. report to view the information.
Registered Capital:
Purchase the Port Pharma I, S. R. O. report to view the information.
Financial Auditors:
Purchase the Port Pharma I, S. R. O. report to view the information.
Incorporation Date:
January 01, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Port Pharma I, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
51.07%▲
Total operating revenue
51.07%▲
Operating profit (EBIT)
77.63%▲
EBITDA
77.63%▲
Net Profit (Loss) for the Period
76.07%▲
Total Assets
42.51%▲
Total Equity
N/A
Operating Profit Margin (ROS)
0.38%▲
Net Profit Margin
0.27%▲
Return on Equity (ROE)
N/A
Debt/Equity
N/A
Quick Ratio
0.1%▲
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo